N-(1-氧代戊基)-N-[[2′-(2H-四唑-5-基)[1,1′-联苯]-4-基]甲基]-<SC>L</SC>-缬氨酸

产品名称：

137862-53-4
Valsartan
N-(1-Oxopentyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-L-valine
缬沙坦
N-(1-氧代戊基)-N-[[2′-(2H-四唑-5-基)[1,1′-联苯]-4-基]甲基]-L-缬氨酸

产品介绍：

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

包装

Unit quantity: 15 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

注意

Please find SDS provided by EDQM here..

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式	C₂₄H₂₉N₅O₃
分子量	435.52
MDL编号	MFCD00865840
PubChem化学物质编号	329830776
NACRES	NA.24

产品性质

等级	pharmaceutical primary standard
manufacturer/tradename	EDQM
application(s)	pharmaceutical (small molecule)
格式	neat
SMILES string	CCCCC(=O)N(Cc1ccc(cc1)-c2ccccc2-c3nnn[nH]3)[C@@H](C(C)C)C(O)=O
InChI	1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1
InChI key	ACWBQPMHZXGDFX-QFIPXVFZSA-N
Gene Information	human ... AGTR1(185)

安全信息

象形图
警示用语：	Warning
危险声明	H336 - H361d
预防措施声明	P201 - P308 + P313
危险分类	Repr. 2 - STOT SE 3
靶器官	Central nervous system
储存分类代码	11 - Combustible Solids
WGK	WGK 3
闪点(F)	Not applicable
闪点(C)	Not applicable